Pharmaceutical Membrane Filtration Market accounted for US$ 5.9 billion in 2020 and is estimated to be US$ 17.54 billion by 2030 and is anticipated to register a CAGR of 11.5%. Membrane filtration is broadly employed in pharmaceutical, biotechnology, and chemical procedures. It has already proved as a valuable means of cleaning and filtering waste liquid and industrial procedure liquid. Furthermore, the use of spiral and tubular sheath plants to screen filths from drinking water has been recently started in areas where the traditional management proved to be wasteful. A membrane is a thin layer of semi-permeable material that separates substances when a driving force is applied across the membrane. Membrane processes are increasingly used for removal of bacteria, microorganisms, particulates, and natural organic material, which can impart color, tastes, and odors to water and react with disinfectants to form disinfection byproducts. As advancements are made in membrane production and module design, capital and operating costs continue to decline.
The report “Global Pharmaceutical Membrane Filtration Market, By Product (Filter, System, and Accessories), By Technique (Microfiltration, Ultrafiltration, Nanofiltration, Reverse Osmosis, and Ion Exchange), By Material (PES, PVDF, Nylon, PTFE, MCE & CA, PCTE, and Other Materials (Polypropylene, Regenerated Cellulose, Gelatin, and PVC), By Application (Final Product Processing (API Filtration, Sterile Filtration, Protein Purification, Vaccine and Antibody Processing, Formulation and Filling Solutions, and Viral Clearance), Raw Material Filtration (Media Buffers, Prefiltration, and Bioburden Reduction), Cell Separation, Water Purification, and Air Purification), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”
Key Highlights:
· In 2018, Pall Corporation partnered with BioSciencesCorp to supply drug manufacturers with direct access to Pall Biotech’s downstream technologies, including pharmaceutical membrane filtration.
· In 2020, Merck invested USD 280.3 million during a new facility—the Merck Biotech Development Center in Corsier-sur-Vevey, Switzerland.
· In 2019, Koch Membrane Systems launched Sani-Pro Spiral Element line.
Analyst View:
The growth of the pharmaceutical membrane filtration market is primarily driven by a factor such as increasing adoption of single-use technologies and advancements in nanofiltration technologies. Also, the stringent environmental protocols and good manufacturing practices (GMP) in the pharmaceutical industry drives the growth of pharmaceutical membrane filtration market. However, membrane fouling concerns and high capital investments for operations are the major challenges faced by the target market.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3859
Key Market Insights from the report:
The Global Pharmaceutical Membrane Filtration Market accounted for US$ 5.9 billion in 2020 and is estimated to be US$ 17.54 billion by 2030 and is anticipated to register a CAGR of 11.5%. The global pharmaceutical membrane filtration market is segmented based on product, technique, material, application, and region.
· By Product, the Global Pharmaceutical Membrane Filtration Market is segmented into filter, system, and accessories.
· By Technique, the Global Pharmaceutical Membrane Filtration Market is segmented into microfiltration, ultrafiltration, nanofiltration, reverse osmosis, and ion exchange.
· By Material, the Global Pharmaceutical Membrane Filtration Market is segmented into PES, PVDF, nylon, PTFE, MCE & CA, PCTE, and other materials.
· By Application, the Global Pharmaceutical Membrane Filtration Market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification.
· By region, the Global Pharmaceutical Membrane Filtration Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The large share of North America can be attributed due to several factors, such as the presence of key biopharmaceutical manufacturing facilities in the region and the significant spending on research and development activities in the U.S.
Competitive Landscape:
The key players operating the global pharmaceutical membrane filtration market involves Merck Millipore, Danaher, Sartorius Stedim Biotech, GE Healthcare, 3M Company, Thermo Fisher Scientific, Repligen Corporation, GEA Group, Parker Hannifin, Koch Membrane Systems. For instance, in 2018, GE Healthcare and the Swedish Government opened an innovation centre—Test Center—in Sweden to support the commercialization of advanced biopharmaceuticals.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
